Search
SAB Biotherapeutics Inc
SABSAdd to Watchlist
3.920USD
+0.040+1.03%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
296.92MMarket Cap
9.17P/E TTM
SAB Biotherapeutics Inc Earnings Date
Period
FY2025 Earnings Date
Revenue(YoY)
--
-100.00%
EPS(YoY)
0.22
105.99%
Analyst Rating
BUY
2026-07-04
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What are the current assets of SAB Biotherapeutics Inc?
According to SAB Biotherapeutics Inc's FY2025 earnings report, its current assets were 101.05M, with a year-on-year change of 324.73.
What are the total assets of SAB Biotherapeutics Inc?
According to SAB Biotherapeutics Inc's FY2025 earnings report, its total assets of SAB Biotherapeutics Inc were 172.81M, with a year-on-year change of 291.01.
What are the total liabilities of SAB Biotherapeutics Inc?
According to SAB Biotherapeutics Inc's FY2025 earnings report, its total liabilities of SAB Biotherapeutics Inc were 21.32M, with a year-on-year change of 16.95.
What is the total equity of SAB Biotherapeutics Inc?
According to SAB Biotherapeutics Inc's FY2025 earnings report, its total equity of SAB Biotherapeutics Inc was 151.49M, with a year-on-year change of 483.35.
What is the net investment of SAB Biotherapeutics Inc?
According to SAB Biotherapeutics Inc's FY2025 earnings report, its net investment of SAB Biotherapeutics Inc was -121.71M, with a year-on-year change of -917.42.
What is the net financing of SAB Biotherapeutics Inc?
According to SAB Biotherapeutics Inc's FY2025 earnings report, its net financing of SAB Biotherapeutics Inc was 168.30M, with a year-on-year change of 14452.36.
What is the Earnings Per Share (EPS) of SAB Biotherapeutics Inc?
According to SAB Biotherapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was 0.22, with a year-on-year change of 105.99.
What is the debt-to-asset ratio of SAB Biotherapeutics Inc?
According to SAB Biotherapeutics Inc's FY2025 earnings report, its debt-to-asset ratio was 1.90, with a year-on-year change of -77.32.
What is the Return on Equity (ROE) of SAB Biotherapeutics Inc?
According to SAB Biotherapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was 4.80, with a year-on-year change of 105.86.
What is the Return on Assets (ROA) of SAB Biotherapeutics Inc?
According to SAB Biotherapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was 12.23, with a year-on-year change of 122.98.
What is the operating profit of SAB Biotherapeutics Inc?
According to SAB Biotherapeutics Inc's FY2025 earnings report, its operating profit was -48.85M, with a year-on-year change of -14.12.